Physician

Adam F. Spitz, MD

According to 2025 Medicare claims, Adam Spitz, MD (NPI: 1013944248) practices endocrinology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Mecklenburg, NC. This provider's primary affiliated billing organization is NOVANT HEALTH MEDICAL GROUP, LLC (NPI: 1588386296; TIN: 581728803) and primary practice location at 28207-1109. Spitz is affiliated with the Novant Health Accountable Care Organization I, LLC (ACO ID: A3504), participating under the MSSP model.

Spitz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 338 traditional Medicare patients, billed 1,410 HCPCS/CPT codes, and received $63,981 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,941 prescription claims across 493 beneficiaries totaling $874,009 in drug costs, led by Sandostatin Lar Depot (Octreotide Acetate,mi-Spheres). DME data shows 496 claims. Open Payments data shows 4 records totaling $263. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $318,033 to $874,009. For DME billing, reported payments moved from a lower plateau to a higher plateau, from $27,448 to $148,228.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	388	912	$58,276
2016	402	882	$59,207
2017	374	804	$53,258
2018	429	1,062	$71,115
2019	466	1,155	$72,520
2020	403	923	$62,202
2021	398	1,073	$85,755
2022	388	1,012	$75,161
2023	368	911	$57,180
2024	338	1,410	$63,981

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	300	1,797	$318,033
2016	308	1,891	$362,855
2017	314	1,712	$398,551
2018	379	1,921	$471,493
2019	466	2,608	$770,952
2020	445	2,432	$779,429
2021	442	2,613	$859,286
2022	436	2,741	$970,167
2023	510	3,120	$1,330,044
2024	493	2,941	$874,009

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	132	387	$41,039
2016	133	452	$46,730
2017	144	372	$63,238
2018	109	365	$73,284
2019	120	477	$99,072
2020	135	565	$104,974
2021	115	685	$139,546
2022	109	681	$126,516
2023	146	736	$141,989
2024	124	496	$156,557

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	289	420	$86
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	76	141	$25
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	324	487	$12
83036	Hemoglobin a1c level	95	132	$10
96127	Assessment of emotional or behavioral problems	79	79	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Sandostatin Lar Depot	Octreotide Acetate,mi-Spheres	22	636	$167,610
Somavert	Pegvisomant	11	330	$129,939
Ozempic	Semaglutide	60	3,341	$108,818
Trulicity	Dulaglutide	35	1,798	$62,903
Farxiga	Dapagliflozin Propanediol	39	2,865	$49,750

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	58	255	$103,196
E0784	External ambulatory infusion pump, insulin	Y	N/R	41	$13,655
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	18	49	$11,630
A4238	Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	19	$11,129
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	24	$9,111

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$263	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam F. Spitz, MD?

Tedicare shows public-source Medicare data for Adam F. Spitz, MD (NPI 1013944248), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam F. Spitz, MD have ACO affiliation data?

Adam F. Spitz, MD is shown with ACO affiliation data for Novant Health Accountable Care Organization I, LLC (MSSP, ACO ID A3504).

What billing organization is linked to Adam F. Spitz, MD?

Adam F. Spitz, MD is linked to NOVANT HEALTH MEDICAL GROUP, LLC (billing NPI 1588386296) in the available physician profile data.

Does Adam F. Spitz, MD have Open Payments data?

Adam F. Spitz, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.